WRAL Tech Wire

 Salix, InKine Shareholders Approve Merger

 Salix Pharmaceuticals to Present at Roth Capital Partners Conference

 Drug Manufacturer Salix Suggests Better Treatment for Relief of Cancer Side Effects

Study suggests relief is in site for patients receiving medical treatment for prostate cancer. Drug may have a new purpose.

 Earnings: Salix Reports Surge in Profits; Inspire Revenues Climb

Salix produces 13-cent a share profit as sales far outpace expenses; Inspire cuts losses as co-marketed drug sales increase; Icagen reports a loss but notes progress on drugs.

 Salix Launches Phase III Trial for New Use of Drug

 Salix To Buy Rival Pharmaceutical Firm for $190M

 Salix Hires Executive To Lead R&D Efforts

 Update: Salix Reports First Profit; Stock Price Soars

 Salix Names New Chief Medical Officer

 TriVirix Sets Pace for 2004 North Carolina 'Top 50' Tech Firms

Deloitte says leading technology firms increase revenues by 599 percent over five years. TriVirix revenues soar 8881 percent.'Rising Stars' include PowerByHand, LVL7.

 Soaring Drug Sales, New Product Have Salix Talking About Profitability

Pharmaceutical firm says Colazal revenue climbs 46 percent, beats analyst expectations. New drug now hitting market. CFO sees $100 million in revenue this year.

 Salix Shipping Xifaxan to Distributors

 Salix Gets a Downgrade After Buying Drug Rights

 $13 Million Deal: Salix Pays Cash To Acquire Four Products

 Salix Posts Positive Q4 Results, Expects Profit as Stock Climbs

<b>Updated:</b> Narrows net loss and grows revenue, on 53 percent increase in Colazal sales. Continued growth will lead to profitability in 2004, Salix says, as stock jumps 17 percent.